Systems toxicology-based assessment of the candidate modified risk tobacco product ThS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells
Non-Clinical
Cardiovascular Toxicity
In Vitro
Poussin (2016)
Use of human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.
Nonclinical
Cardiovascular Toxicity
In Vitro
Simms (2022)
A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation
Non-clinical
Cardiovascular Toxicity
In Vitro
Shields (2017)